Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.

Coppry M, Jeanne-Leroyer C, Noize P, Dumartin C, Boyer A, Bertrand X, Dubois V, Rogues AM.

J Antimicrob Chemother. 2018 Oct 29. doi: 10.1093/jac/dky427. [Epub ahead of print]

PMID:
30376042
2.

Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.

Tsao LH, Hsin CY, Liu HY, Chuang HC, Chen LY, Lee YJ.

J Microbiol Immunol Infect. 2018 Jun;51(3):359-366. doi: 10.1016/j.jmii.2017.08.015. Epub 2017 Sep 6.

3.

Risk factors and influence of carbapenem exposure on the development of carbapenem resistant Pseudomonas aeruginosa bloodstream infections and infections at sterile sites.

Barron MA, Richardson K, Jeffres M, McCollister B.

Springerplus. 2016 Jun 17;5(1):755. doi: 10.1186/s40064-016-2438-4. eCollection 2016.

4.

Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.

Lin KY, Lauderdale TL, Wang JT, Chang SC.

J Microbiol Immunol Infect. 2016 Feb;49(1):52-9. doi: 10.1016/j.jmii.2014.01.005. Epub 2014 Mar 21.

5.

[Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].

Cekin Y, Karagöz A, Kızılateş F, Cekin AH, Oztoprak Çuvalcı N, Bülbüller N, Durmaz R.

Mikrobiyol Bul. 2013 Oct;47(4):619-27. Turkish.

6.

Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.

Kohlenberg A, Weitzel-Kage D, van der Linden P, Sohr D, Vögeler S, Kola A, Halle E, Rüden H, Weist K.

J Hosp Infect. 2010 Apr;74(4):350-7. doi: 10.1016/j.jhin.2009.10.024. Epub 2010 Feb 19.

PMID:
20170982
7.

Gastrointestinal microbiota disruption and risk of colonization with carbapenem-resistant Pseudomonas aeruginosa in ICU patients.

Pettigrew MM, Gent JF, Kong Y, Halpin AL, Pineles L, Harris AD, Johnson JK.

Clin Infect Dis. 2018 Nov 1. doi: 10.1093/cid/ciy936. [Epub ahead of print]

PMID:
30383203
8.

High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit.

Chaves L, Tomich LM, Salomão M, Leite GC, Ramos J, Martins RR, Rizek C, Neves P, Batista MV, Amigo U, Guimaraes T, Levin AS, Costa SF.

J Med Microbiol. 2017 Dec;66(12):1722-1729. doi: 10.1099/jmm.0.000631. Epub 2017 Nov 2.

PMID:
29095142
9.

Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria.

Meradji S, Barguigua A, Zerouali K, Mazouz D, Chettibi H, Elmdaghri N, Timinouni M.

Antimicrob Resist Infect Control. 2015 Jun 12;4:27. doi: 10.1186/s13756-015-0067-2. eCollection 2015.

10.

Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis.

Liu Q, Li X, Li W, Du X, He JQ, Tao C, Feng Y.

Sci Rep. 2015 Jun 25;5:11715. doi: 10.1038/srep11715.

11.

The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.

Zou Y, Lian J, Di Y, You H, Yao H, Liu J, Dong Y.

Int J Clin Pharm. 2018 Feb;40(1):175-182. doi: 10.1007/s11096-017-0524-5. Epub 2017 Nov 14.

PMID:
29134489
12.

Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.

Zavascki AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL.

J Antimicrob Chemother. 2005 Dec;56(6):1148-51. Epub 2005 Oct 20.

PMID:
16239284
13.

Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome.

Jeong SJ, Yoon SS, Bae IK, Jeong SH, Kim JM, Lee K.

Diagn Microbiol Infect Dis. 2014 Oct;80(2):130-5. doi: 10.1016/j.diagmicrobio.2014.07.003. Epub 2014 Jul 17.

PMID:
25112900
14.

Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.

Rojo-Bezares B, Estepa V, Cebollada R, de Toro M, Somalo S, Seral C, Castillo FJ, Torres C, Sáenz Y.

Int J Med Microbiol. 2014 May;304(3-4):405-14. doi: 10.1016/j.ijmm.2014.01.001. Epub 2014 Feb 6.

PMID:
24594145
15.

Metallo-β-lactamase-mediated resistance among clinical carbapenem-resistant Pseudomonas aeruginosa isolates in northern Iran: A potential threat to clinical therapeutics.

Dogonchi AA, Ghaemi EA, Ardebili A, Yazdansetad S, Pournajaf A.

Ci Ji Yi Xue Za Zhi. 2018 Apr-Jun;30(2):90-96. doi: 10.4103/tcmj.tcmj_101_17.

16.

Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.

Cai Y, Yang D, Wang J, Wang R.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):186-190. doi: 10.1016/j.diagmicrobio.2018.01.023. Epub 2018 Feb 2.

PMID:
29486972
17.

[Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors].

Álvarez-Otero J, Lamas-Ferreiro JL, González-González L, Rodríguez-Conde I, Fernández-Soneira MJ, Arca-Blanco A, Bermúdez-Sanjurjo JR, de la Fuente-Aguado J.

Rev Esp Quimioter. 2017 Jun;30(3):183-194. Epub 2017 Apr 25. Spanish.

18.

Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.

Akhi MT, Khalili Y, Ghotaslou R, Yousefi S, Kafil HS, Naghili B, Sheikhalizadeh V.

Microb Drug Resist. 2018 Mar;24(2):126-135. doi: 10.1089/mdr.2016.0310. Epub 2017 Jun 27.

PMID:
28654368
19.

Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance.

Cohen MJ, Block CS, Moses AE, Nir-Paz R.

Clin Microbiol Infect. 2014 Mar;20(3):O188-96. doi: 10.1111/1469-0691.12362. Epub 2013 Sep 18. Erratum in: Clin Microbiol Infect. 2015 Sep;21(9):e65-7.

20.

Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.

Wu D, Cai J, Liu J.

South Med J. 2011 Feb;104(2):106-10. doi: 10.1097/SMJ.0b013e318206063d.

PMID:
21258230

Supplemental Content

Support Center